• Science and Research

  Orkambi Benefits CF Patients Across Levels of Lung Health, Study Finds

  Posted by cystic-fibrosis-news-moderator on July 17, 2020 at 10:00 am

  

  A real-world study of Orkambi’s use by 827 patients, including those kept from trials, supported its broad label based on lung function and weight gains. Click here to learn more.

  What do you think of this news?

  cystic-fibrosis-news-moderator replied 3 years, 9 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply